Last Updated

16 Jun 2015

Phase Ib Trial of MSP3 LSP in Children in Tanzania

Objectives

This study will evaluate the safety of candidate malaria vaccine MSP3 in children aged 12-24 months in Tanzania in a highland area with low malaria transmission.

Principal Investigator

Date

2007 Oct - 2008 Aug
Project Site